The allergic rhinitis drugs market is projected to reach $20 billion by 2030 at a 4.2% CAGR, driven by biologics, personalized therapies, and digital allergy management.
Read More
The alkylating agents market is projected to reach $6.9 billion by 2030 at a 5.2% CAGR, driven by oncology pipeline growth, combination therapies, and cancer screening programs.
Read More
The alkaloid-based drugs market is projected to reach $4.8 billion by 2030 at an 8.8% CAGR, driven by plant-derived therapeutics, oncology applications, and extraction innovations.
Read More
The alexipharmic drugs market is projected to reach $4.02 billion by 2030 at a 4.5% CAGR, driven by antidote innovations, AI diagnostics, and growing homecare adoption.
Read More
Alcohol-free disinfectant foam market to reach $4.44 billion by 2030 at 14% CAGR, driven by increasing focus on hygiene and cleanliness.
Read More
The alcohol excipients market is projected to reach $4.66 billion by 2030 at an 8.2% CAGR, driven by biologics growth, personalized medicine, and advanced drug delivery.
Read More
The albuterol sulfate metered dose inhalers market is projected to reach $7.61 billion by 2030 at an 8.1% CAGR, driven by eco-friendly inhalers, homecare use, and patient-centric designs.
Read More
The albuterol market is projected to reach $6.57 billion by 2030 at a 6.8% CAGR, driven by rising asthma & COPD cases, homecare therapies, and rapid-relief inhalers.
Read More
The albumin excipient market is projected to reach $7.15 billion by 2030 at a 6.9% CAGR, driven by biopharma growth, protein excipient innovations, and advanced drug delivery.
Read More
The AI in bioinformatics market is projected to reach $37.63 billion by 2030 at a 43.7% CAGR, driven by precision medicine, AI-driven drug discovery, and genomic data analysis.
Read More